Neurotech Notables #5: March 2024

Q2, Here We Come

Neurotech was on fire this quarter. A conservative tally of Q1 2024:

$400m raised in private capital. Over 20 FDA decisions. 2 public offerings. A handful of new coverage decisions, along with dozens …